Predictive value of T1 mapping in cervical cancer recurrence after treatment
Jie Liu1, Shujian Li1, Qinchen Cao1, Marcel Dominik Nickel2, Jingliang Cheng1, and Jinxia Zhu3
1the First Affiliated Hospital of Zhengzhou University, Zheng zhou, China, 2MR Application Predevelopment, Siemens Healthcare GmbH, Erlangen, Germany, 3MR Collaboration, Siemens Healthineers Ltd., Beijing, China
We investigated the feasibility of T1-mapping to predict cervical cancer (CC) recurrence after treatment. Our results show that quantitative T1 values of the primary tumor could effectively predict the CC recurrence after surgery or concurrent chemoradiotherapy (CCRT). These findings suggest that the T1-mapping method could be valuable for evaluating CC recurrence after treatment, and native T1 values of the primary tumor could predict cervical cancer recurrence.
This abstract and the presentation materials are available to members only;
a login is required.